Health
Sanofi’s mRNA COVID-19 vaccine candidate not ready this year – CEO By Reuters – Investing.com UK
Sanofi’s mRNA COVID-19 vaccine candidate not ready this year – CEO
PARIS (Reuters) – A COVID-19 vaccine candidate developed by Sanofi (PA:SASY) and U.S. group Translate Bio “will not be ready this year,” the French drugmaker’s chief executive told Le Journal du Dimanche newspaper.
Clinical trials of this vaccine, which will be based on a technology known as mRNA — on which lean approved vaccines of Pfizer/BioNTech and Moderna (NASDAQ:MRNA) –, are expected to start this quarter.
In December last year, Sanofi had said it was targeting “earliest potential approval”…
-
Noosa News23 hours agoUnlawful wounding charges, Caloundra – Sunshine Coast
-
Business16 hours agoThis artificial intelligence (AI) and “Magnificent Seven” stock will be the next company to surpass a $3 trillion market cap by the end of 2025
-
General15 hours ago‘Hidden and radical’ power of First Nations women unlocked in big hART’s Punkaliyarra project
-
General17 hours agoWest Indies-Australia live: Third day-night Test in Jamaica